Dodge & Cox

Holding/activity history for  GSK plc (GSK)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2024   Q3 50,047,977 1.82 $40.88
2024   Q2 50,047,977 1.81 $38.50
2024   Q1 50,047,977 1.98 $42.87
2023   Q4 50,047,977 1.91 $37.06
2023   Q3 50,047,977 1.99 Add 0.54% 0.01 $36.25
2023   Q2 49,780,637 1.95 Add 0.37% 0.01 $35.64
2023   Q1 49,599,557 2.01 Add 9.10% 0.17 $35.58
2022   Q4 45,460,757 1.84 Buy 1.84 $35.14
2022   Q3 0 0 Sell 100.00% 2.66
2022   Q2 51,376,172 2.66 Reduce 13.26% 0.41 $43.53
2022   Q1 59,228,772 2.68 $43.56
2021   Q4 59,228,772 2.73 Add 0.72% 0.02 $44.10
2021   Q3 58,806,872 2.49 Add 0.11% 0.00 $38.21
2021   Q2 58,741,472 2.67 Add 0.76% 0.02 $39.82
2021   Q1 58,296,600 2.65 Add 40.38% 0.76 $35.69
2020   Q4 41,528,300 2.18 Add 42.80% 0.65 $36.80
2020   Q3 29,082,200 1.82 Add 11.49% 0.19 $37.64
2020   Q2 26,084,900 1.79 Reduce 6.79% 0.13 $40.79
2020   Q1 27,984,900 2.08 Reduce 9.45% 0.22 $37.89
2019   Q4 30,905,200 1.97 Reduce 3.22% 0.07 $46.99
2019   Q3 31,935,000 2.01 $42.68
2019   Q2 31,935,000 1.85 $40.02
2019   Q1 31,935,000 1.98 Reduce 0.20% 0.00 $41.79
2018   Q4 32,000,000 2.02 $38.21
2018   Q3 32,000,000 1.76 $40.17
2018   Q2 32,000,000 1.87 $40.31
2018   Q1 32,000,000 1.83 Add 10.59% 0.18 $39.07
2017   Q4 28,936,700 1.47 Add 163.30% 0.91 $35.47
2017   Q3 10,990,050 0.66 Buy 0.66 $40.60
2015   Q3 0 0 Sell 100.00% 0.40
2015   Q2 5,717,547 0.40 Reduce 48.40% 0.38 $41.65
2015   Q1 11,081,400 0.86 Reduce 2.64% 0.02 $46.15
2014   Q4 11,381,400 0.82 Reduce 30.30% 0.36 $42.74
2014   Q3 16,329,300 1.30 Reduce 33.17% 0.65 $45.97
2014   Q2 24,435,300 2.25 $53.48
2014   Q1 24,435,300 2.40 Reduce 1.09% 0.03 $53.43
2013   Q4 24,703,400 2.44 Reduce 1.98% 0.05 $53.39
2013   Q3 25,203,400 2.59 $50.17
2013   Q2 25,203,400 2.75 Reduce 1.63% 0.05 $49.97
2013   Q1 25,621,200 2.72 Reduce 0.19% 0.01 $46.91
2012   Q4 25,671,200 2.83 Add 9.74% 0.25 $43.47
2012   Q3 23,392,100 2.71 Add 4.70% 0.12 $46.24
2012   Q2 22,342,100 2.70 Reduce 2.40% 0.07 $45.57
2012   Q1 22,892,100 2.55 Reduce 1.71% 0.04 $44.91
2011   Q4 23,290,800 2.92 Reduce 4.12% 0.13 $45.63
2011   Q3 24,290,800 2.95 Reduce 13.01% 0.44 $41.29
2011   Q2 27,925,000 2.76 $42.90
2011   Q1 27,925,000 2.41 Add 1.29% 0.03 $38.41
2010   Q4 27,569,000 2.54 Reduce 0.92% 0.02 $39.22
2010   Q3 27,824,300 2.79 Reduce 0.71% 0.02 $39.52
2010   Q2 28,024,300 2.62 Add 0.72% 0.02 $34.01
2010   Q1 27,824,300 2.55 $38.52
2009   Q4 27,824,300 2.99 $42.25
2009   Q3 27,824,300 2.83 $39.51
2009   Q2 27,824,300 2.98 Reduce 0.05% 0.00 $35.34
2009   Q1 27,838,300 3.28 Reduce 3.80% 0.13 $31.07
2008   Q4 28,938,300 3.37 Reduce 5.86% 0.21 $37.27
2008   Q3 30,738,300 3.03 Reduce 4.06% 0.13 $43.46
2008   Q2 32,038,300 2.74 Add 0.04% 0.00 $44.22
2008   Q1 32,025,900 2.54 Add 1.93% 0.05 $42.43
2007   Q4 31,420,700 2.54 Add 0.01% 0.00 $50.39
2007   Q3 31,418,900 2.46 Add 3.97% 0.09 $53.20
2007   Q2 30,218,900 2.25 Add 22.51% 0.41 $52.37
2007   Q1 24,666,900 2.08 Add 68.22% 0.84 $55.26
2006   Q4 14,663,800 1.22 $52.76